Kamada (KMDA) VP Regulatory Affairs reports initial shares and option grants
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Kamada Ltd executive Orit Pinchuk, VP Regulatory Affairs, filed an initial Form 3 reporting her equity position in the company. She directly holds 12,133 Ordinary Shares.
She also holds several option grants to purchase Ordinary Shares, including one grant exercisable for 15,000 shares at $6.15 per share, expiring on August 28, 2028, and additional grants each covering 15,000 shares at $7.55 per share with an expiration date of October 22, 2035 and different future exercise dates. The options are exercisable using a net-exercise method, and the U.S. dollar exercise prices are convenience translations from NIS based on the Bank of Israel exchange rate as of March 13, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Pinchuk Orit
Role
VP Regulatory Affairs
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Options to purchase Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Options to purchase Ordinary Shares — 15,000 shares (Direct);
Ordinary Shares — 12,133 shares (Direct)
Footnotes (1)
- These options to purchase ordinary shares are exercisable using a net-exercise method All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.
FAQ
What does the Kamada (KMDA) Form 3 filing by Orit Pinchuk report?
The Form 3 reports VP Regulatory Affairs Orit Pinchuk’s initial equity holdings in Kamada. It details her direct ownership of Ordinary Shares and multiple option grants, including exercise prices, expiration dates, and the net-exercise feature translated from NIS to U.S. dollars.
What stock options are disclosed for Orit Pinchuk in the Kamada (KMDA) Form 3?
The filing lists several options to purchase Kamada Ordinary Shares. One grant is for 15,000 shares at an exercise price of $6.15 expiring August 28, 2028, plus additional 15,000-share grants at $7.55 expiring October 22, 2035, with staged exercise dates.
What are the exercise prices and expirations of Orit Pinchuk’s Kamada (KMDA) options?
One option grant covers 15,000 Ordinary Shares at $6.15 per share, expiring August 28, 2028. Several other grants each cover 15,000 shares at $7.55 per share, all expiring October 22, 2035, but with different future exercise dates before expiration.
How are the Kamada (KMDA) option exercise prices translated in Orit Pinchuk’s Form 3?
All exercise prices shown in U.S. dollars are convenience translations from Israeli shekels. They use the representative exchange rate of the Bank of Israel as of March 13, 2026, as noted in the filing’s footnote on currency conversion.
What does net-exercise mean for Orit Pinchuk’s Kamada (KMDA) stock options?
Her options are exercisable using a net-exercise method, according to the footnote. In a net-exercise, the option holder typically receives fewer shares instead of paying cash, with some shares effectively covering the exercise cost at settlement.